The results of our study show that PTBP3 expression is increased in a tumour cell line selected for lymphatic metastasis and provides direct evidence supporting the hypothesis that the inhibition of PTBP3 can block tumour lymphangiogenesis and suppress lymph node metastasis. Here, PTBP3 is linked to neoplasm.